Page last updated: 2024-08-23

pravastatin and Diathesis

pravastatin has been researched along with Diathesis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kückelhaus, CS; Kückelhaus, SA; Muniz-Junqueira, MI	1
Ehrenborg, E; Karpe, F; Ledmyr, H; Lithell, H; MacFarlane, PW; McMahon, AD; Neville, M; Nielsen, LB; Packard, CJ	1
Hofman, A; Pols, HA; Schoofs, MW; Stricker, BH; Sturkenboom, MC; van der Klift, M	1

Trials

1 trial(s) available for pravastatin and Diathesis

Article	Year
The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation, 2004, May-18, Volume: 109, Issue:19 Topics: Abetalipoproteinemia; Anticholesteremic Agents; Biopsy; Carrier Proteins; Case-Control Studies; Cholesterol, LDL; Codon; Cohort Studies; Coronary Disease; Disease Susceptibility; Double-Blind Method; Genotype; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardium; Polymorphism, Genetic; Pravastatin; Promoter Regions, Genetic; Prospective Studies; Risk; RNA, Messenger; Scotland; Sweden	2004

Article

Year

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.

Circulation, 2004, May-18, Volume: 109, Issue:19

Topics: Abetalipoproteinemia; Anticholesteremic Agents; Biopsy; Carrier Proteins; Case-Control Studies; Cholesterol, LDL; Codon; Cohort Studies; Coronary Disease; Disease Susceptibility; Double-Blind Method; Genotype; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardium; Polymorphism, Genetic; Pravastatin; Promoter Regions, Genetic; Prospective Studies; Risk; RNA, Messenger; Scotland; Sweden

2004

Other Studies

2 other study(ies) available for pravastatin and Diathesis

Article	Year
Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis. Experimental parasitology, 2011, Volume: 127, Issue:3 Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Statistics, Nonparametric; Survival Rate	2011
HMG-CoA reductase inhibitors and the risk of vertebral fracture. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:9 Topics: Aged; Bone Density; Cohort Studies; Disease Susceptibility; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lumbar Vertebrae; Male; Middle Aged; Pravastatin; Risk; Spinal Fractures	2004

Article

Year

Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.

Experimental parasitology, 2011, Volume: 127, Issue:3

Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Statistics, Nonparametric; Survival Rate

2011

HMG-CoA reductase inhibitors and the risk of vertebral fracture.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:9

Topics: Aged; Bone Density; Cohort Studies; Disease Susceptibility; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lumbar Vertebrae; Male; Middle Aged; Pravastatin; Risk; Spinal Fractures

2004